Richard Forth

589 total citations
24 papers, 447 citations indexed

About

Richard Forth is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Animal Science and Zoology. According to data from OpenAlex, Richard Forth has authored 24 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 18 papers in Pulmonary and Respiratory Medicine and 3 papers in Animal Science and Zoology. Recurrent topics in Richard Forth's work include Asthma and respiratory diseases (22 papers), Respiratory and Cough-Related Research (15 papers) and Inhalation and Respiratory Drug Delivery (11 papers). Richard Forth is often cited by papers focused on Asthma and respiratory diseases (22 papers), Respiratory and Cough-Related Research (15 papers) and Inhalation and Respiratory Drug Delivery (11 papers). Richard Forth collaborates with scholars based in United Kingdom, United States and South Africa. Richard Forth's co-authors include Loretta Jacques, Eric D. Bateman, Ashley Woodcock, Jan Lötvall, Eugene R. Bleecker, Paul M. O’Byrne, Brett Haumann, Angela Davis, William W. Busse and Eugene R. Bleecker and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Richard Forth

24 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Forth United Kingdom 11 411 395 23 18 14 24 447
J Małolepszy Poland 6 374 0.9× 349 0.9× 13 0.6× 36 2.0× 7 0.5× 10 452
Denise Till Switzerland 7 489 1.2× 571 1.4× 10 0.4× 6 0.3× 8 0.6× 11 595
Leslie Baitinger United States 7 580 1.4× 536 1.4× 39 1.7× 46 2.6× 44 3.1× 9 613
Moira H. Thomson United Kingdom 7 463 1.1× 540 1.4× 11 0.5× 7 0.4× 12 0.9× 9 593
Tito Atienza Sweden 5 566 1.4× 544 1.4× 17 0.7× 71 3.9× 23 1.6× 5 583
Andrzej Dymek Poland 6 310 0.8× 303 0.8× 19 0.8× 19 1.1× 34 2.4× 13 348
Claire Houghton New Zealand 5 275 0.7× 254 0.6× 7 0.3× 26 1.4× 15 1.1× 8 311
R. Cameron United Kingdom 10 382 0.9× 467 1.2× 19 0.8× 4 0.2× 9 0.6× 14 506
Christer Hultquist Sweden 11 527 1.3× 510 1.3× 41 1.8× 54 3.0× 48 3.4× 12 581
Nancy L. Hordvik United States 10 176 0.4× 268 0.7× 18 0.8× 12 0.7× 9 0.6× 10 306

Countries citing papers authored by Richard Forth

Since Specialization
Citations

This map shows the geographic impact of Richard Forth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Forth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Forth more than expected).

Fields of papers citing papers by Richard Forth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Forth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Forth. The network helps show where Richard Forth may publish in the future.

Co-authorship network of co-authors of Richard Forth

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Forth. A scholar is included among the top collaborators of Richard Forth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Forth. Richard Forth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bareille, Philippe, et al.. (2024). Once-daily fluticasone furoate/vilanterol vs once-daily fluticasone furoate in patients with asthma aged 5 to 17 years. Annals of Allergy Asthma & Immunology. 133(5). 537–544.e4. 1 indexed citations
2.
Busse, William W., David A. Stempel, Bhumika Aggarwal, et al.. (2022). Insights from the AUSTRI study on reliever use before and after asthma exacerbations. The Journal of Allergy and Clinical Immunology In Practice. 10(7). 1916–1918.e2. 7 indexed citations
3.
Reddel, Helen K., William Busse, Klaus F. Rabe, et al.. (2021). Heterogeneity and time course of asthma exacerbations: data from AUSTRI. PA3716–PA3716. 1 indexed citations
4.
Martin, Neil, John M. Weiler, David S. Pearlman, et al.. (2019). Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction. Journal of Asthma. 57(4). 431–440. 4 indexed citations
5.
Kerwin, Edward, Neil Barnes, M.R.J. Gibbs, et al.. (2017). Fluticasone furoate/vilanterol once daily improves night-time awakenings in asthma patients with night symptoms: Post hoc analyses of three randomized controlled trials. Journal of Asthma. 55(8). 890–897. 1 indexed citations
6.
Bernstein, David I., et al.. (2017). Comparison of Once Daily Fluticasone Furoate/Vilanterol With Twice Daily Fluticasone Propionate/Salmeterol in Patients With Controlled Asthma. CHEST Journal. 152(4). A186–A186. 2 indexed citations
7.
8.
Bernstein, David I., Eric D. Bateman, Ashley Woodcock, et al.. (2015). Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma. Journal of Asthma. 52(10). 1073–1083. 37 indexed citations
9.
Bleecker, Eugene R., Jan Lötvall, Paul M. O’Byrne, et al.. (2014). Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial. The Journal of Allergy and Clinical Immunology In Practice. 2(5). 553–561. 39 indexed citations
10.
Bateman, Eric D., Paul M. O’Byrne, Jan Lötvall, et al.. (2014). Once‐daily fluticasone furoate 50 mcg in mild‐to‐moderate asthma: a 24‐week placebo‐controlled randomized trial. Allergy. 69(11). 1522–1530. 20 indexed citations
11.
Lötvall, Jan, Eugene R. Bleecker, Paul M. O’Byrne, et al.. (2013). Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial. Respiratory Medicine. 108(1). 41–49. 31 indexed citations
12.
Busse, William W., Eric D. Bateman, Paul M. O’Byrne, et al.. (2013). Efficacy and safety of once-daily (OD) fluticasone furoate (FF) 50mcg over 24 weeks in adults and adolescents with persistent asthma. 42. 3397. 1 indexed citations
13.
Bateman, Eric D., Eugene R. Bleecker, Jan Lötvall, et al.. (2012). Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial. Respiratory Medicine. 106(5). 642–650. 57 indexed citations
14.
Lötvall, Jan, Eugene R. Bleecker, William W. Busse, et al.. (2012). Efficacy and safety of once-daily (OD) fluticasone furoate (FF) in patients with persistent asthma: A 24-week randomised trial. 40. 2123. 2 indexed citations
15.
Bleecker, Eugene R., Jan Lötvall, Ashley Woodcock, et al.. (2012). Efficacy of fluticasone furoate (FF) as a monotherapy and in combination with vilanterol (VI) over 12 weeks in patients with persistent asthma. 40. 2091. 8 indexed citations
16.
Busse, William W., Eugene R. Bleecker, Eric D. Bateman, et al.. (2011). Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial. Thorax. 67(1). 35–41. 67 indexed citations
17.
Woodcock, Ashley, Eric D. Bateman, Jan Lötvall, et al.. (2011). Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial. Respiratory Research. 12(1). 132–132. 38 indexed citations
18.
Busse, William W., Eric D. Bateman, Eugene R. Bleecker, et al.. (2011). Fluticasone Furoate (FF), A Once-Daily Inhaled Corticosteroid (ICS), Is Efficacious In Patients With Uncontrolled Asthma Across A Range Of Treatment Steps. A1298–A1298. 2 indexed citations
19.
Solomon, Anthony W., et al.. (2010). Urine output on an intensive care unit: case-control study. BMJ. 341(dec14 1). c6761–c6761. 26 indexed citations
20.
Forth, Richard. (1998). Common Questions About Obstructive Sleep Apnea. AJN American Journal of Nursing. 98(2). 60–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Małolepszy Breakdown of academic impact, for papers by Denise Till Breakdown of academic impact, for papers by Leslie Baitinger Breakdown of academic impact, for papers by Moira H. Thomson Breakdown of academic impact, for papers by Tito Atienza Breakdown of academic impact, for papers by Andrzej Dymek Breakdown of academic impact, for papers by Claire Houghton Breakdown of academic impact, for papers by R. Cameron Breakdown of academic impact, for papers by Christer Hultquist Breakdown of academic impact, for papers by Nancy L. Hordvik
Rankless by CCL
2026